ALLO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Allogene Therapeutics (ALLO) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ALLO is expected to report earnings to rise 9.97% to -35 cents per share on February 26

Allogene Therapeutics ALLO Stock Earnings Reports

Q4'24

Est.

$-0.35

Q3'24

Beat

by $0.01

Q2'24

Est.

$-0.35

Q1'24

Beat

by $0.03

Q4'23

Missed

by $0.06

The last earnings report on November 07 showed earnings per share of -31 cents, beating the estimate of -33 cents. With 2.62M shares outstanding, the current market capitalization sits at 515.79M.

View a ticker or compare two or three

Compare

ALLO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ALLO
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of allogeneic chimeric antigen receptor therapy

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

210 East Grand Avenue

Phone

+1 650 457-2700

Employees

233

Web

https://www.allogene.com